173 related articles for article (PubMed ID: 38243292)
1. MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.
Yu G; Zhang Z; Eresen A; Hou Q; Garcia EE; Yu Z; Abi-Jaoudeh N; Yaghmai V; Zhang Z
J Transl Med; 2024 Jan; 22(1):76. PubMed ID: 38243292
[TBL] [Abstract][Full Text] [Related]
2. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma.
Che F; Xu Q; Li Q; Huang ZX; Yang CW; Wang LY; Wei Y; Shi YJ; Song B
World J Gastroenterol; 2022 Apr; 28(14):1479-1493. PubMed ID: 35582676
[TBL] [Abstract][Full Text] [Related]
3. Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI.
Eresen A; Sun C; Zhou K; Shangguan J; Wang B; Pan L; Hu S; Ma Q; Yang J; Zhang Z; Yaghmai V
Acad Radiol; 2022 Sep; 29(9):1378-1386. PubMed ID: 34933803
[TBL] [Abstract][Full Text] [Related]
4. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Based on Contrast-Enhanced CT for Recognizing c-Met-Positive Hepatocellular Carcinoma: a Noninvasive Approach to Predict the Outcome of Sorafenib Resistance.
Gu J; Bao S; Akemuhan R; Jia Z; Zhang Y; Huang C
Mol Imaging Biol; 2023 Dec; 25(6):1073-1083. PubMed ID: 37932610
[TBL] [Abstract][Full Text] [Related]
6. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
7. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided interventional natural killer cell delivery for liver tumor treatment.
Su Z; Wang X; Zheng L; Lyu T; Figini M; Wang B; Procissi D; Shangguan J; Sun C; Pan L; Qin L; Zhang B; Velichko Y; Salem R; Yaghmai V; Larson AC; Zhang Z
Cancer Med; 2018 May; 7(5):1860-1869. PubMed ID: 29601672
[TBL] [Abstract][Full Text] [Related]
10. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
11. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
Hectors SJ; Lewis S; Besa C; King MJ; Said D; Putra J; Ward S; Higashi T; Thung S; Yao S; Laface I; Schwartz M; Gnjatic S; Merad M; Hoshida Y; Taouli B
Eur Radiol; 2020 Jul; 30(7):3759-3769. PubMed ID: 32086577
[TBL] [Abstract][Full Text] [Related]
12. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
Ma Y; Gong Y; Qiu Q; Ma C; Yu S
BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract][Full Text] [Related]
14. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
15. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation.
Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L
Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862
[TBL] [Abstract][Full Text] [Related]
16. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts.
Tran A; Koh TS; Prawira A; Ho RZW; Le TBU; Vu TC; Hartano S; Teo XQ; Chen WC; Lee P; Thng CH; Huynh H
Mol Imaging Biol; 2021 Feb; 23(1):70-83. PubMed ID: 32909245
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma.
Eresen A; Pang Y; Zhang Z; Hou Q; Chen Z; Yu G; Wang Y; Yaghmai V; Zhang Z
Am J Cancer Res; 2024; 14(1):344-354. PubMed ID: 38323279
[TBL] [Abstract][Full Text] [Related]
19. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
[TBL] [Abstract][Full Text] [Related]
20. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
